A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Multiple Ascending Doses of ASP7962 in Healthy Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
48
Participants
Timeline
Start Date
May 31, 2014
Primary Completion Date
November 30, 2015
Study Completion Date
November 30, 2015
Conditions
Healthy VolunteersPharmacokinetics of ASP7962
Interventions
DRUG
ASP7962
Oral
DRUG
Placebo
Oral
Trial Locations (1)
HA13UJ
Site GB44001 Parexel Early Phase Clinical Unit, London
All Listed Sponsors
lead
Astellas Pharma Europe B.V.
INDUSTRY
NCT02136316 - A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Multiple Ascending Doses of ASP7962 in Healthy Subjects | Biotech Hunter | Biotech Hunter